• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

集中式放射治疗系统能否提供足够的医疗服务?

Does a centralized radiotherapy system provide adequate access to care?

作者信息

Mackillop W J, Groome P A, Zhang-Solomons J, Zhou Y, Feldman-Stewart D, Paszat L, Dixon P, Holowaty E J, Cummings B J

机构信息

Department of Oncology, Queen's University, Canada.

出版信息

J Clin Oncol. 1997 Mar;15(3):1261-71. doi: 10.1200/JCO.1997.15.3.1261.

DOI:10.1200/JCO.1997.15.3.1261
PMID:9060571
Abstract

PURPOSE

In the Canadian province of Ontario, all radiotherapy is provided by a centrally managed provincial network of nine cancer centers. The primary goal of this study was to determine whether this highly centralized radiotherapy system provides adequate and equitable access to care for the province's dispersed population.

METHODS

The Ontario Cancer Registry (OCR) was used to identify 295,386 cases of invasive cancer, excluding nonmelanoma skin cancer, which were diagnosed in Ontario between 1984 and 1991. Electronic radiotherapy records from each of the province's radiotherapy centers were linked to the registry at the level of the individual case.

RESULTS

The proportion of incident cases treated with radiotherapy was 18.8% at 4 months after diagnosis, 23.7% at 1 year, 25.8% at 2 years, 28.2% at 5 years, and 29.1% at 8 years. These rates of radiotherapy use are much lower than the accepted national and international targets, and lower than rates reported from other jurisdictions. The rate of radiotherapy use at 1 year varied significantly from county to county across Ontario (range, 18.6% to 32.4%; P < 10(-6)), and the highest rates were recorded in communities close to radiotherapy centers. There was a common geographic pattern of rate variations among several disease groups, including breast cancer, lung cancer, the genitourinary malignancies, and the gastrointestinal malignancies.

CONCLUSION

The low and uneven rates of radiotherapy use across the province indicate that Ontario's centralized radiotherapy system does not, at present, provide adequate or equitable access to care.

摘要

目的

在加拿大安大略省,所有放射治疗均由一个由九个癌症中心组成的省级中央管理网络提供。本研究的主要目标是确定这种高度集中的放射治疗系统是否能为该省分散的人口提供充足且公平的医疗服务。

方法

利用安大略癌症登记处(OCR)识别出1984年至1991年间在安大略省诊断出的2953个月时接受放射治疗的新发病例比例为18.8%,1年时为23.7%,2年时为25.8%,5年时为28.2%,8年时为29.1%。这些放射治疗使用率远低于公认的国内和国际目标,也低于其他司法管辖区报告的比率。安大略省各郡之间1年时的放射治疗使用率差异显著(范围为18.6%至32.4%;P < 10⁻⁶),最高使用率出现在靠近放射治疗中心的社区。包括乳腺癌、肺癌、泌尿生殖系统恶性肿瘤和胃肠道恶性肿瘤在内的几个疾病组中,存在共同的地理使用率变化模式。

结论

全省放射治疗使用率低且不均衡,表明安大略省目前的集中放射治疗系统未能提供充足或公平的医疗服务。 例,不包括非黑色素瘤皮肤癌。该省各放射治疗中心的电子放射治疗记录在个体病例层面与登记处相链接。

结果

诊断后4个月时接受放射治疗的新发病例比例为18.8%,1年时为23.7%,2年时为25.8%,5年时为28.2%,8年时为29.1%。这些放射治疗使用率远低于公认的国内和国际目标,也低于其他司法管辖区报告的比率。安大略省各郡之间1年时的放射治疗使用率差异显著(范围为18.6%至32.4%;P < 10⁻⁶),最高使用率出现在靠近放射治疗中心的社区。包括乳腺癌、肺癌、泌尿生殖系统恶性肿瘤和胃肠道恶性肿瘤在内的几个疾病组中,存在共同的地理使用率变化模式。

结论

全省放射治疗使用率低且不均衡,表明安大略省目前的集中放射治疗系统未能提供充足或公平的医疗服务。

相似文献

1
Does a centralized radiotherapy system provide adequate access to care?集中式放射治疗系统能否提供足够的医疗服务?
J Clin Oncol. 1997 Mar;15(3):1261-71. doi: 10.1200/JCO.1997.15.3.1261.
2
Improving the Quality of Radiation Treatment for Patients in Ontario: Increasing Peer Review Activities on a Jurisdictional Level Using a Change Management Approach.提高安大略省患者的放射治疗质量:采用变革管理方法在辖区层面增加同行评审活动。
J Oncol Pract. 2016 Jan;12(1):81-2, e61-70. doi: 10.1200/JOP.2015.006882.
3
Factors affecting the use of palliative radiotherapy in Ontario.安大略省姑息性放射治疗使用的影响因素。
J Clin Oncol. 2001 Jan 1;19(1):137-44. doi: 10.1200/JCO.2001.19.1.137.
4
Estimating the need for palliative radiotherapy for brain metastasis: a benchmarking approach.评估脑转移瘤姑息性放疗的需求:一种基准化方法。
Clin Oncol (R Coll Radiol). 2015 Feb;27(2):83-91. doi: 10.1016/j.clon.2014.11.001. Epub 2014 Dec 4.
5
Geographical variation in radiotherapy services across the UK in 2007 and the effect of deprivation.2007年英国放疗服务的地理差异及贫困的影响。
Clin Oncol (R Coll Radiol). 2009 Aug;21(6):431-40. doi: 10.1016/j.clon.2009.05.006. Epub 2009 Jun 27.
6
Reconstructing cancer services in Ontario.安大略省癌症服务的重建。
Healthc Pap. 2004;5(1):69-80; discussion 96-9. doi: 10.12927/hcpap..16843.
7
Could changes in clinical practice reduce waiting lists for radiotherapy?临床实践的改变能否减少放疗等候名单?
J Health Serv Res Policy. 2001 Apr;6(2):70-7. doi: 10.1258/1355819011927251.
8
Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs.安大略癌症护理新药物资助计划:昂贵抗癌药物的可控引入。
Chronic Dis Can. 2002 Fall;23(4):152-6.
9
Estimating the Need for Palliative Radiation Therapy: A Benchmarking Approach.估算姑息性放疗需求:基准方法。
Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):51-59. doi: 10.1016/j.ijrobp.2015.09.045. Epub 2015 Oct 9.
10
Associations among socioeconomic status, patterns of care and outcomes in breast cancer patients in a universal health care system: Ontario's experience.全民医疗保健系统中乳腺癌患者的社会经济地位、护理模式与治疗结果之间的关联:安大略省的经验
Cancer. 2016 Mar 15;122(6):893-8. doi: 10.1002/cncr.29838. Epub 2015 Dec 22.

引用本文的文献

1
Estimating the optimal perioperative chemotherapy utilization rate for muscle-invasive bladder cancer.估算肌层浸润性膀胱癌的最佳围手术期化疗使用率。
Cancer Med. 2019 Oct;8(14):6258-6271. doi: 10.1002/cam4.2449. Epub 2019 Aug 31.
2
Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer.估算 III 期结肠癌辅助化疗的最佳利用速度。
Cancer Med. 2019 Sep;8(12):5590-5599. doi: 10.1002/cam4.2456. Epub 2019 Aug 12.
3
How many roads must a Malaysian walk down? Mapping the accessibility of radiotherapy facilities in Malaysia.
马来西亚人要走多少条路?绘制马来西亚放射治疗设施可达性地图。
PLoS One. 2019 Mar 21;14(3):e0213583. doi: 10.1371/journal.pone.0213583. eCollection 2019.
4
Patient preferences for timing and access to radiation therapy.患者对放疗时间安排和放疗机会的偏好。
Curr Oncol. 2015 Aug;22(4):279-86. doi: 10.3747/co.22.2532.
5
Decentralisation of radiation therapy. Is it possible and beneficial to patients? Experience of the first 5 years of a satellite radiotherapy unit in the province of Tarragona, Spain.放射治疗的去中心化。这对患者是否可行且有益?西班牙塔拉戈纳省一家卫星放射治疗单位头五年的经验。
Rep Pract Oncol Radiother. 2014 Nov 8;20(2):141-4. doi: 10.1016/j.rpor.2014.10.008. eCollection 2015 Mar-Apr.
6
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence.随机对照试验与基于人群的观察性研究:医学证据发展中的合作伙伴。
Br J Cancer. 2014 Feb 4;110(3):551-5. doi: 10.1038/bjc.2013.725. Epub 2014 Jan 14.
7
Cross-disciplinary research in cancer: an opportunity to narrow the knowledge-practice gap.癌症领域的跨学科研究:缩小知识-实践差距的机会。
Curr Oncol. 2013 Dec;20(6):e512-21. doi: 10.3747/co.20.1487.
8
Responses by breast and prostate cancer patients to out-of-pocket costs in Newfoundland and Labrador.纽芬兰和拉布拉多的乳腺癌和前列腺癌患者对自付费用的反应。
Curr Oncol. 2013 Jun;20(3):158-65. doi: 10.3747/co.20.1197.
9
How do surgeons decide to refer patients for adjuvant cancer treatment? Protocol for a qualitative study.外科医生如何决定为患者转介辅助癌症治疗?一项定性研究的方案。
Implement Sci. 2012 Oct 25;7:102. doi: 10.1186/1748-5908-7-102.
10
How should we describe the benefits of palliative radiotherapy?我们应该如何描述姑息性放疗的获益?
Curr Oncol. 2006 Dec;13(6):230-4. doi: 10.3747/co.v13i6.108.